PARENTERALE ESMOLOLFORMULIERUNG
European patent · EP2846776 · In force
Register entry
- Publication number
- EP2846776
- Application number
- EP13721740
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- May 8, 2013
- Published
- Mar 18, 2015
- Granted
- Apr 15, 2020
- Protection ends at the latest
- May 7, 2033
- Next annual fee due
- May 31, 2027
- IPC classes
- A61K 9/19 (2006.01)A61K 9/00 (2006.01)A61K 9/08 (2006.01)A61K 31/24 (2006.01)A61P 9/06 (2006.01)
- Priority
- EP 12167443 10.05.2012
- PCT application
- PCT/EP2013/059594 08.05.2013
- PCT publication
- WO2013/167657 14.11.2013
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Aug 20, 2026
Next annual fee due on
- Next annual fee due on
- 31.05.2026 → 31.05.2027
Published in Swissreg on 20.08.2026
- Jun 12, 2025
Next annual fee due on
- Next annual fee due on
- 31.05.2025 → 31.05.2026
Published in Swissreg on 12.06.2025
- Jun 2, 2024
Change
Published in Swissreg on 02.06.2024
- Jun 1, 2023
Change
Published in Swissreg on 01.06.2023
- Jul 5, 2022
Address changed
- Owner
- AOP Orphan Pharmaceuticals AG, Wilhelminenstrasse 91/II f, 1160 Wien, Austria → AOP Orphan Pharmaceuticals GmbH, Leopold-Ungar-Platz 2, 1190 Vienna, Austria
Published in Swissreg on 05.07.2022
- Jun 4, 2020
Agent entered
- Representative
- Katzarov SA, Avenue des Morgines 12, 1213 Petit-Lancy
Published in Swissreg on 04.06.2020
- Apr 15, 2020
Granted
Published in Swissreg on 15.04.2020
Parties
Inventor
WIDMANN, Rudolf
A-3002 Purkersdorf, AT
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.